IP Library Assignment 074114/0582
Patent Assignment
Reel/Frame 074114/0582

Release of Security Interest

Recorded: 2026-03-18 Pages: 16
Assignor
PIPER SANDLER FINANCE, LLC
Executed: 2026-03-17
Assignees
INDIVIOR INC.
10710 MIDLOTHIAN TURNPIKE, SUITE 125, NORTH CHESTERFIELD, VIRGINIA, 23235
INDIVIOR UK LIMITED
234 BATH RD, SLOUGH, SL1 4EE, UNITED KINGDOM
Covered Properties (43)
Compositions and Methods for the Treatment of Opioid Overdose
Application: 16/461,354 →
Publication: US 2020/0060967
Methods, Parenteral Pharmaceutical Formulations, and Devices for the Prevention of Opioid Overdose
Application: 17/291,979 →
Publication: US 2021/0401827
Compositions and Methods for the Treatment of Opioid Overdose
Application: 17/881,306 →
Publication: US 2023/0055547
Methods, Parenteral Pharmaceutical Formulations, and Devices for the Prevention of Opioid Overdose
Application: 18/174,858 →
Publication: US 2023/0225961
Formulations and Methods for the Prevention of Opioid Overdose
Application: 18/436,976 →
Publication: US 2024/0197719
Compositions and Methods for the Treatment of Opioid Overdose
Application: 18/753,188 →
Publication: US 2025/0127712
Sublingual and Buccal Film Compositions
Patent: 8,475,832 →
Application: 12/537,571 →
Publication: US 2011/0033541
Injectable Flowable Composition Comprising Buprenorphine
Patent: 8,921,387 →
Application: 13/703,013 →
Publication: US 2013/0210853
Compositions Comprising Buprenorphine
Patent: 9,295,645 →
Application: 13/703,015 →
Publication: US 2013/0202658
Injectable Flowable Composition Comprising Buprenorphine
Patent: 8,975,270 →
Application: 13/836,134 →
Publication: US 2013/0203796
Injectable Flowable Composition Buprenorphine
Patent: 9,272,044 →
Application: 14/610,818 →
Publication: US 2015/0216988
Sublingual and Buccal Film Compositions
Patent: 9,687,454 →
Application: 14/989,669 →
Publication: US 2016/0113885
Injectable Flowable Composition Comprising Buprenorphine
Patent: 9,498,432 →
Application: 14/995,053 →
Publication: US 2016/0128934
Compositions Comprising Buprenorphine
Application: 15/060,184 →
Publication: US 2016/0184296
Sustained-Release Buprenorphine Solutions
Application: 15/125,052 →
Publication: US 2017/0079974
Injectable Composition Comprising Buprenorphine
Patent: 9,782,402 →
Application: 15/334,000 →
Publication: US 2017/0079976
Therapeutic Compounds as Inhibitors of the Orexin-1 Receptor
Application: 15/508,392 →
Publication: US 2017/0291897
Dopamine D3 Receptor Antagonist Compounds
Application: 15/522,863 →
Publication: US 2017/0334895
Buprenorphine Dosing Regimens
Application: 15/523,986 →
Publication: US 2017/0354653
Injectable Flowable Composition Comprising Buprenorphine
Patent: 9,827,241 →
Application: 15/623,191 →
Publication: US 2017/0281618
Injectable Flowable Composition Comprising Buprenorphine
Application: 15/820,048 →
Publication: US 2018/0157440
Injectable Flowable Composition Comprising Buprenorphine
Application: 15/857,507 →
Publication: US 2018/0121137
Substituted Hexahydropyrrolo[3,4-B]Pyrroles and Hexahydrocyclopenta[C]Pyrroles as Dopamine Receptor Modulators
Application: 15/750,128 →
Publication: US 2018/0222918
Dopamine D3 Receptor Antagonists Having a Morpholine Moiety
Application: 15/767,328 →
Publication: US 2018/0297990
Dopamine D3 Receptor Antagonists
Application: 15/975,466 →
Publication: US 2018/0282318
Sustained-Release Buprenorphine Solutions
Application: 16/016,186 →
Publication: US 2019/0022085
Methods to Treat Opioid Use Disorder
Application: 16/016,250 →
Publication: US 2018/0360821
Syringe System
Application: 16/041,170 →
Publication: US 2019/0380909
Therapeutic Compounds
Application: 16/073,429 →
Publication: US 2019/0040041
Dopamine D3 Receptor Antagonist Compounds
Application: 16/261,206 →
Publication: US 2019/0300514
Substituted 3,6-Diazabicyclo[3.2.0]Heptanes
Application: 16/292,110 →
Publication: US 2019/0194225
Sublingual and Buccal Film Compositions
Application: 16/439,530 →
Publication: US 2020/0030313
Injectable Flowable Composition Comprising Buprenorphine
Application: 16/693,726 →
Publication: US 2020/0089436
Therapeutic Compounds as Inhibitors of the Orexin-1 Receptor
Application: 16/814,328 →
Publication: US 2020/0270247
Therapeutic Compounds
Application: 16/860,572 →
Publication: US 2020/0255404
Buprenorphine Dosing Regimens
Application: 17/217,914 →
Publication: US 2022/0031692
Buprenorphine to Treat Respiratory Depression
Application: 17/283,931 →
Publication: US 2021/0393618
Therapeutic Compounds
Application: 17/459,598 →
Publication: US 2021/0395227
Syringe System
Application: 17/947,887 →
Publication: US 2023/0149262
Buprenorphine Dosing Regimens
Application: 17/985,253 →
Publication: US 2023/0077787
Therapeutic Compounds
Application: 18/225,966 →
Publication: US 2024/0076282
Rapid Induction of Monthly Injectable Buprenorphine Extended-Release (Bup-Xr) Compared to Standard of Care Induction
Application: 63/544,747 →
Methods for Administering Buprenorphine
Application: 63/594,785 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 22, 2012
From: RECKITT BENCKISER HEALTHCARE (UK) LIMITED
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 029167/0310 →
Assignment of Assignor's Interest Oct 26, 2012
From: MONOSOL RX, LLC
To: RECKITT BENCKISER HEALTHCARE (UK) LIMITED
Reel/Frame 029196/0344 →
Security Agreement Dec 18, 2012
From: MONOSOL RX, LLC
To: WHITE OAK GLOBAL ADVISORS, LLC, AS AGENT
Reel/Frame 029490/0156 →
Assignment of Assignor's Interest Apr 21, 2014
From: NORTON, RICHARD L; WATKINS, ANDREW; ZHOU, MINGXING
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 032716/0951 →
Release of Security Interest Aug 28, 2014
From: CREDIT SUISSE AG
To: ALCATEL LUCENT
Reel/Frame 033654/0968 →
Release of Security Interest Dec 8, 2014
From: WHITE OAK GLOBAL ADVISORS, LLC
To: MONOSOL RX, LLC
Reel/Frame 034421/0737 →
Grant of Security Interest in Patents Dec 23, 2014
From: RB PHARMACEUTICALS LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC. AS COLLATERAL AGENT
Reel/Frame 034696/0885 →
Security Interest Mar 17, 2015
From: RB PHARMACEUTICALS LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 035186/0121 →
Assignment of Assignor's Interest May 8, 2015
From: NORTON, RICHARD L.; WATKINS, ANDREW; ZHOU, MINGXING
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 035601/0154 →
Change of Name Aug 18, 2015
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 036388/0861 →
Change of Name Dec 4, 2015
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 037218/0769 →
Change of Name Feb 16, 2016
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 037837/0908 →
Notice of Grant of Security Interest in Patents May 10, 2016
From: INDIVIOR UK LIMITED, FORMERLY RB PHAMACEUTICALS LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 038658/0700 →
Release of Security Interest Aug 22, 2016
From: WHITE OAK GLOBAL ADVISORS, LLC
To: MONOSOL RX, LLC
Reel/Frame 039774/0782 →
Assignment of Assignor's Interest Sep 9, 2016
From: MONOSOL RX, LLC
To: RECKITT BENCKISER HEALTHCARE (UK) LIMITED
Reel/Frame 039690/0551 →
Assignment of Assignor's Interest Sep 9, 2016
From: RECKITT BENCKISER HEALTHCARE (UK) LIMITED
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 039690/0714 →
Assignment of Assignor's Interest Sep 9, 2016
From: MYERS, GARRY L.; HILBERT, SAMUEL D.; BOONE, BILL J.; BOGUE, B. ARLIE
To: MONOSOL RX, LLC
Reel/Frame 039690/0606 →
Change of Name Sep 9, 2016
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 039981/0280 →
Change of Name Oct 13, 2016
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 040351/0089 →
Assignment of Assignor's Interest Oct 13, 2016
From: NORTON, RICHARD L.; WATKINS, ANDREW; ZHOU, MINGXING
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 040010/0055 →
Change of Name Nov 7, 2016
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 040575/0332 →
Change of Name Feb 2, 2017
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 041591/0741 →
Assignment of Assignor's Interest Feb 2, 2017
From: NORTON, RICHARD L.; WATKINS, ANDREW; ZHOU, MINGXING
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 041155/0056 →
Assignment of Assignor's Interest Mar 27, 2017
From: BLANEY, EMMA LOUISE; MARTIN, BARRIE PHILLIP; NOWAK, THORSTEN; WATSON, MARTIN JOHN
To: C4X DISCOVERY LIMITED
Reel/Frame 041747/0984 →
Assignment of Assignor's Interest Feb 13, 2018
From: ZHOU, MINGXING; NORTON, RICHARD
To: INDIVIOR UK LIMITED
Reel/Frame 044912/0376 →